Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TTLL7 intronic transcript 1 (TTLL7-IT1) is a long non-coding RNA (lncRNA) gene, meaning it transcribes to RNA but does not encode a protein[3]. It is located within the TTLL7 locus but is classified as non-protein coding and affiliated with the lncRNA class[3]. There are no known biological functions, disease associations, therapeutic uses, or drug interactions directly related to TTLL7-IT1 at this time. No evidence from these sources suggests TTLL7-IT1 is itself a therapeutic target, biomarker, or involved in recognized disease pathways[3][4]. The main biological and pharmacological interest lies with the TTLL7 protein-coding gene, not with the non-coding TTLL7-IT1 transcript[2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TTLL7 intronic transcript 1 (TTLL7-IT1).